156 related articles for article (PubMed ID: 10200128)
1. Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness.
Sato N; Sugimura T; Akagi T; Yamakawa R; Hashino K; Eto G; Iemura M; Ishii M; Kato H
Pediatr Int; 1999 Feb; 41(1):1-7. PubMed ID: 10200128
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease.
Furukawa S; Matsubara T; Umezawa Y; Motohashi T; Ino T; Yabuta K
Eur J Pediatr; 1994 Sep; 153(9):663-7. PubMed ID: 7957426
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose.
Terai M; Shulman ST
J Pediatr; 1997 Dec; 131(6):888-93. PubMed ID: 9427895
[TBL] [Abstract][Full Text] [Related]
4. Intravenous gamma-globulin for Kawasaki disease.
Furusho K; Kamiya T; Nakano H; Kiyosawa N; Shinomiya K; Hayashidera T; Tamura T; Hirose O; Manabe Y; Yokoyama T
Acta Paediatr Jpn; 1991 Dec; 33(6):799-804. PubMed ID: 1801560
[TBL] [Abstract][Full Text] [Related]
5. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of plasmin-treated intravenous gamma-globulin for therapy of Kawasaki syndrome.
Hsu CH; Chen MR; Hwang FY; Kao HA; Hung HY; Hsu CH
Pediatr Infect Dis J; 1993 Jun; 12(6):509-12. PubMed ID: 8345983
[TBL] [Abstract][Full Text] [Related]
8. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.
Newburger JW; Takahashi M; Beiser AS; Burns JC; Bastian J; Chung KJ; Colan SD; Duffy CE; Fulton DR; Glode MP
N Engl J Med; 1991 Jun; 324(23):1633-9. PubMed ID: 1709446
[TBL] [Abstract][Full Text] [Related]
9. High-dose intravenous gammaglobulin for Kawasaki disease.
Furusho K; Kamiya T; Nakano H; Kiyosawa N; Shinomiya K; Hayashidera T; Tamura T; Hirose O; Manabe Y; Yokoyama T
Lancet; 1984 Nov; 2(8411):1055-8. PubMed ID: 6209513
[TBL] [Abstract][Full Text] [Related]
10. Patients diagnosed with Kawasaki disease before the fifth day of illness have a higher risk of coronary artery aneurysm.
Nomura Y; Masuda K; Yoshinaga M; Sameshima K; Miyata K
Pediatr Int; 2002 Aug; 44(4):353-7. PubMed ID: 12139556
[TBL] [Abstract][Full Text] [Related]
11. Overview of pharmacological treatment of Kawasaki disease.
Onouchi Z; Kawasaki T
Drugs; 1999 Nov; 58(5):813-22. PubMed ID: 10595862
[TBL] [Abstract][Full Text] [Related]
12. [Study on coronary artery lesions in patients with Kawasaki disease: recent 9 years' experience].
Wu JR; Hwang KP; Tu JG; Dai ZK; Huang TY
Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Jan; 9(1):27-38. PubMed ID: 7682261
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.
Song D; Yeo Y; Ha K; Jang G; Lee J; Lee K; Son C; Lee J
Eur J Pediatr; 2009 Nov; 168(11):1315-21. PubMed ID: 19159953
[TBL] [Abstract][Full Text] [Related]
14. Coronary risk factors in acute Kawasaki disease: correlation of serum immunoglobulin levels with coronary complications.
Sawaji Y; Haneda N; Yamaguchi S; Kajino Y; Kishida K; Seto S; Konishi N; Waki K; Baba K; Arisawa K; Kamiya T; Mori C
Acta Paediatr Jpn; 1998 Jun; 40(3):218-25. PubMed ID: 9695293
[TBL] [Abstract][Full Text] [Related]
15. Coronary risks after high-dose gamma-globulin in children with Kawasaki disease.
Morikawa Y; Ohashi Y; Harada K; Asai T; Okawa S; Nagashima M; Katoh T; Baba K; Furusho K; Okuni M; Osano M
Pediatr Int; 2000 Oct; 42(5):464-9. PubMed ID: 11059532
[TBL] [Abstract][Full Text] [Related]
16. The treatment of Kawasaki syndrome with intravenous gamma globulin.
Newburger JW; Takahashi M; Burns JC; Beiser AS; Chung KJ; Duffy CE; Glode MP; Mason WH; Reddy V; Sanders SP
N Engl J Med; 1986 Aug; 315(6):341-7. PubMed ID: 2426590
[TBL] [Abstract][Full Text] [Related]
17. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
Newburger JW; Sleeper LA; McCrindle BW; Minich LL; Gersony W; Vetter VL; Atz AM; Li JS; Takahashi M; Baker AL; Colan SD; Mitchell PD; Klein GL; Sundel RP;
N Engl J Med; 2007 Feb; 356(7):663-75. PubMed ID: 17301297
[TBL] [Abstract][Full Text] [Related]
19. [Clinical manifestations and effects of IVGG in patients with Kawasaki disease].
Hwang KP; Wu JR; Huang LY; Liou CC; Huang TY
Kaohsiung J Med Sci; 1996 Mar; 12(3):159-66. PubMed ID: 8709183
[TBL] [Abstract][Full Text] [Related]
20. Management of Kawasaki disease in the British Isles.
Dhillon R; Newton L; Rudd PT; Hall SM
Arch Dis Child; 1993 Dec; 69(6):631-6; discussion 637-8. PubMed ID: 8285773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
